HLB will establish the right direction of management by enacting the Corporate Governance Charter,
share values with customers, shareholders, executives, and employees, and become a more trusted company.
| Category | 2020 | 2021 | 2022 |
| Total | C | B | - |
| Environment | D | B | - |
| Society | B | B+ | - |
| Governance | C | B | - |
| Recommendation | Acceptance | Note |
| Introduction of Corporate Governance Charter | ◯ | 2021.02.28 |
| Introduction of ethics regulations for executives and employees | ◯ | 2019 |
| Composition of Board of Directors (majority of outside directors) | X | 7 inside, 3 outside |
| Separation between the CEO and the chairman of the board of directors | X | - |
| Disclosure of the details of activities of the board of directors, attendance rate, and pros and cons of major agenda items | ◯ | - |
| An intensive voting system | X | - |
| Composition of outside director candidate recommendation committee | X | - |
| Composition of compensation committee | X | - |
| Formation of an audit committee (all outside directors) | X | - |
| Introduction of regulations on the roles and operating procedures of the board of directors and various committees | ◯ | 2021.08.25 |
| Director's liability insurance at the company's expense | ◯ | Directors & Officers Liability (annual) |
| Evaluation of the activities of the board of directors | ◯ | - |
| Maintaining independence of external auditors | ◯ | - |
| Certification of accuracy and completeness of financial reporting by the Representative Director and Financial Officer | ◯ | - |
| Description of differences from the criteria | ◯ | Website |
(unit: KRW)
| Sort | 2019 | 2020 | 2021 | |
| Environmental law |
Penalty | - | - | - |
| No. of violations | - | - | - | |
| Unfair transaction (including corruption and bribery) | Penalty | - | - | - |
| No. of violations | - | - | - | |
| Regulations related to domestic marketing activities | Penalty | - | - | - |
| No. of violations | - | - | - | |
| Customer information protection | Penalty | - | - | - |
| No. of violations | - | - | - | |
| Product information provision notice | Penalty | - | - | - |
| No. of violations | - | - | - | |
| Regulations related to counterfeit products | Penalty | - | - | - |
| No. of violations | - | - | - | |
| Clinical trial regulations in developing countries | Penalty | - | - | - |
| No. of violations | - | - | - | |
| Regulations of the Act on the Health and Safety Impact of Products and Services and No. of cases in violation of autonomous regulations |
Penalty | - | - | - |
| No. of violations | - | - | - |